Healthcare provider profile · identity verified

Ann E Stapleton, MD

Internal Medicine · PALM SPRINGS, CA · NPI 1851477582

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	809	91
Atorvastatin Calcium	Atorvastatin Calcium	504	126
Tivicay	Dolutegravir Sodium	382	45
Descovy	Emtricitabine/Tenofov Alafenam	262	34
Rosuvastatin Calcium	Rosuvastatin Calcium	248	83
Lisinopril	Lisinopril	229	61
Testosterone	Testosterone	226	54
Triumeq	Abacavir/Dolutegravir/Lamivudi	195	25
Prezcobix	Darunavir/Cobicistat	194	21
Juluca	Dolutegravir/Rilpivirine	189	23
Alprazolam	Alprazolam	170	30
Testosterone Cypionate	Testosterone Cypionate	162	38
Zolpidem Tartrate	Zolpidem Tartrate	153	38
Tamsulosin Hcl	Tamsulosin Hcl	152	40
Pifeltro	Doravirine	151	17
Acyclovir	Acyclovir	135	37
Valacyclovir	Valacyclovir Hcl	135	36
Metformin Hcl	Metformin Hcl	127	30
Amlodipine Besylate	Amlodipine Besylate	126	38
Gabapentin	Gabapentin	121	26
Lorazepam	Lorazepam	111	32
Omeprazole	Omeprazole	102	31
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	98	suppressed
Ezetimibe	Ezetimibe	97	25
Losartan Potassium	Losartan Potassium	96	31
Bupropion Xl	Bupropion Hcl	94	25
Cabenuva	Cabotegravir/Rilpivirine	93	17
Dovato	Dolutegravir Sodium/Lamivudine	90	11
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	90	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	83	17
Levothyroxine Sodium	Levothyroxine Sodium	77	22
Eliquis	Apixaban	71	13
Metformin Hcl Er	Metformin Hcl	70	22
Metoprolol Succinate	Metoprolol Succinate	70	19
Hydrochlorothiazide	Hydrochlorothiazide	69	15
Clonazepam	Clonazepam	68	15
Duloxetine Hcl	Duloxetine Hcl	68	12
Pantoprazole Sodium	Pantoprazole Sodium	65	14
Albuterol Sulfate Hfa	Albuterol Sulfate	55	14
Escitalopram Oxalate	Escitalopram Oxalate	55	13
Atenolol	Atenolol	53	13
Finasteride	Finasteride	53	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	53	suppressed
Symtuza	Darunavir/Cob/Emtri/Tenof Alaf	53	suppressed
Montelukast Sodium	Montelukast Sodium	49	suppressed
Fluticasone Propionate	Fluticasone Propionate	48	14
Ozempic	Semaglutide	48	suppressed
Trazodone Hcl	Trazodone Hcl	48	13
Ritonavir	Ritonavir	47	11
Pravastatin Sodium	Pravastatin Sodium	46	12
Pregabalin	Pregabalin	46	11
Sertraline Hcl	Sertraline Hcl	46	13
Edurant	Rilpivirine Hcl	45	suppressed
Allopurinol	Allopurinol	44	11
Serostim	Somatropin	41	suppressed
Celecoxib	Celecoxib	40	12
Vascepa	Icosapent Ethyl	39	suppressed
Meloxicam	Meloxicam	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Efavirenz	Efavirenz	37	suppressed
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Fenofibrate	Fenofibrate	35	suppressed
Tradjenta	Linagliptin	33	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Isentress	Raltegravir Potassium	31	suppressed
Ketoconazole	Ketoconazole	31	suppressed
Maraviroc	Maraviroc	31	suppressed
Aripiprazole	Aripiprazole	30	suppressed
Abacavir-Lamivudine	Abacavir Sulfate/Lamivudine	29	suppressed
Ondansetron Odt	Ondansetron	29	suppressed
Oxycontin	Oxycodone Hcl	29	suppressed
Temazepam	Temazepam	29	17
Alendronate Sodium	Alendronate Sodium	27	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Egrifta Sv	Tesamorelin Acetate	26	suppressed
Nevirapine	Nevirapine	25	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Diazepam	Diazepam	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Famotidine	Famotidine	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Tadalafil	Tadalafil	22	suppressed
Carvedilol	Carvedilol	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	14
Entecavir	Entecavir	21	suppressed
Loperamide	Loperamide Hcl	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Nevirapine Er	Nevirapine	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Eszopiclone	Eszopiclone	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	suppressed
Cevimeline Hcl	Cevimeline Hcl	18	suppressed
Darunavir	Darunavir	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Etravirine	Etravirine	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Potassium Chloride	Potassium Chloride	16	suppressed
Icosapent Ethyl	Icosapent Ethyl	15	suppressed
Lamivudine	Lamivudine	15	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	14	suppressed
Isentress Hd	Raltegravir Potassium	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Abacavir	Abacavir Sulfate	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Estradiol	Estradiol	13	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Rukobia	Fostemsavir Tromethamine	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Trogarzo	Ibalizumab-Uiyk	13	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Emtricitabine-Tenofovir Disop	Emtricitabine/Tenofovir (Tdf)	12	suppressed
Famciclovir	Famciclovir	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Simvastatin	Simvastatin	12	suppressed
Stribild	Elviteg/Cob/Emtri/Tenofo Disop	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	11	suppressed
Glipizide	Glipizide	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Symproic	Naldemedine Tosylate	11	suppressed
Triazolam	Triazolam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error